Form D · Biotechnology

ProNova Solutions, LLC

Knoxville, TN · CIK 0001561817

Offering snapshot reported Nov 18, 2014 · SEC filing

Reported sold
$2.7M
Indefinite offering
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 1, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 18, 2014Initial$2,702,460No comparison12SEC filing
Nov 14, 2014Initial$30,000,000No comparison20SEC filing
Nov 13, 2012Initial$7,500,000No comparison1SEC filing

Offering details

Securities
Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-228536

Source: Form D, filed Nov 18, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

R/CRYPTO FUND I LP

Investment adviser: REPUBLIC CAPITAL ADVISER LLC

Gross asset value
$53.5M
Beneficial owners
88
ADV minimum commitment
$500K

Reported in Form ADV on Feb 23, 2024. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator FORMIDIUM DOWNERS GROVE, Illinois, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor RICHEY, MAY & CO., LLP ENGLEWOOD, California, United States
Custodian FIREBLOCKS NEW YORK, New York, United States Related to adviser: No
Custodian SILVERGATE BANK LA JOLLA, California, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

RICHEY, MAY & CO., LLP
PCAOB 673

Filing source

Form ADV 1822318 · Feb 23, 2024 · Schedule D 7.B.(1), fund 805-1993866284

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Stephen Arnold Executive
James Blankemeyer Director
James Blankmeyer Director
Chris Brown Executive
Tracy Dobbs Director
Terry D. Douglass Director, Executive
Mary Lou Du Bois Director, Executive
Mary Lou Du Bois Director, Executive
Adam Kuhn Executive
Joseph Matteo Director, Executive
David Millhorn Director
Mike J. Sommi Executive
Thomas Welch Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6450 Provision Cares Way
Knoxville, TN, 37909